Digitalisierung von Therapieprotokollen

Wickenkamp, Axel; Dresel, Annika; Lengen, Rolf Hendrik van

doi:10.1007/s12312-020-00762-7

Cited by 3 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The data are stored in XML, like in the Czech library, and are available for members of the German Oncologic Society on the Internet 17 . This comprehensive initiative not only adds guidelines for recommended supportive treatment to the core oncology regimens, but also advices on the optimal order of administration of drugs and features the ability to export the library regimens to software systems for ordering and compounding chemotherapy that are widely used in Germany and Austria 18 …”

Section: Resultsmentioning

confidence: 99%

“…17 This comprehensive initiative not only adds guidelines for recommended supportive treatment to the core oncology regimens, but also advices on the optimal order of administration of drugs and features the ability to export the library regimens to software systems for ordering and compounding chemotherapy that are widely used in Germany and Austria. 18 The UK initiative is called SACT and consists of a database containing both adult as well as paediatric oncology treatment regimens.…”

Section: European Based Libraries and Codification Approachesmentioning

confidence: 99%

See 1 more Smart Citation

Identifying options for oncology therapy regimen codification to improve standardization—combined results of an expert panel and a review

Terkola

Bardin

Cundin³

et al. 2021

J Clin Pharm Ther

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Section: European Based Libraries and Codification Approachesmentioning

confidence: 99%

Identifying options for oncology therapy regimen codification to improve standardization—combined results of an expert panel and a review

Terkola

Bardin

Cundin³

et al. 2021

J Clin Pharm Ther

View full text Add to dashboard Cite

show abstract

“…Diese Protokolle können in Anwendungssoftware wie BD-Cato, Microsoft Excel oder proprietäre Programme exportiert werden. Dadurch entsteht eine erhebliche Prozessoptimierung der Verordnung und Durchführung der medikamentösen Therapie maligner Erkrankungen [4].…”

Section: Transfer In Die Praxis Von Prof Dr Hartmut Link (Kaiserslaunclassified

Antiemese: Die Neuerungen der ASCO-Guideline im Überblick

Link

2021

Kompass Onkol

Self Cite

View full text Add to dashboard Cite

Purpose: To update the guideline to include new anticancer agents, antiemetics, and antiemetic regimens and to provide recommendations on the use of dexamethasone as a prophylactic antiemetic in patients receiving checkpoint inhibitors (CPIs). Methods: ASCO convened an Expert Panel and updated the systematic review to include randomized controlled trials (RCTs) and meta-analyses of RCTs published between June 1, 2016, and January 24, 2020. To address the dexamethasone and CPI question, we conducted a systematic review of RCTs that evaluated the addition of a CPI to chemotherapy. Results: The systematic reviews included 3 publications from the updated search and 10 publications on CPIs. Two phase III trials in adult patients with non–small-cell lung cancers evaluating a platinum-based doublet with or without the programmed death 1 (PD-1) inhibitor pembrolizumab recommended that all patients receive dexamethasone as a component of the prophylactic antiemetic regimen. In both studies, superior outcomes were noted in the PD-1 inhibitor–containing arms. Other important findings address olanzapine in adults and fosaprepitant in pediatric patients. Recommendations: Recommendations for adults are unchanged with the exception of the option of adding olanzapine in the setting of hematopoietic stem cell transplantation. Dosing information now includes the option of a 5-mg dose of olanzapine in adults and intravenous formulations of aprepitant and netupitant-palonosetron. The option of fosaprepitant is added to pediatric recommendations. There is no clinical evidence to warrant omission of dexamethasone from guideline-compliant prophylactic antiemetic regimens when CPIs are administered to adults in combination with chemotherapy. CPIs administered alone or in combination with another CPI do not require the routine use of a prophylactic antiemetic. Additional information is available at www.asco.org/supportive-care-guidelines.

show abstract